Home/Filings/4/0001209191-19-050504
4//SEC Filing

Andrews William T. 4

Accession 0001209191-19-050504

CIK 0001069308other

Filed

Sep 22, 8:00 PM ET

Accepted

Sep 23, 7:35 PM ET

Size

5.6 KB

Accession

0001209191-19-050504

Insider Transaction Report

Form 4
Period: 2019-09-18
Andrews William T.
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-09-18+40,00040,000 total
    Exercise: $3.42Exp: 2029-09-18Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as follows: 50% on 01/01/2021 and 50% on 01/01/2022.

Issuer

Acer Therapeutics Inc.

CIK 0001069308

Entity typeother

Related Parties

1
  • filerCIK 0001638459

Filing Metadata

Form type
4
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 7:35 PM ET
Size
5.6 KB